Neisseria meningitidis Strains Isolated from Invasive Infections in France (1999–2002): Phenotypes and Antibiotic Susceptibility Patterns
Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%...
Saved in:
Published in | Clinical infectious diseases Vol. 37; no. 7; pp. 912 - 920 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Chicago, IL
The University of Chicago Press
01.10.2003
University of Chicago Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for ∼30% of isolates during this period, warranting continued surveillance of this phenomenon. |
---|---|
AbstractList | Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for approximately 30% of isolates during this period, warranting continued surveillance of this phenomenon. Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999–2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for ∼30% of isolates during this period, warranting continued surveillance of this phenomenon. Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for similar to 30% of isolates during this period, warranting continued surveillance of this phenomenon. |
Author | Pirès, René Ducos-Galand, Magaly Alonso, Jean-Michel Antignac, Aude Taha, Muhamed-Kheir Guiyoule, Annie |
Author_xml | – sequence: 1 givenname: Aude surname: Antignac fullname: Antignac, Aude organization: Unité des Neisseria and Centre National de Référence des Méningocoques, Institut Pasteur, Paris, France – sequence: 2 givenname: Magaly surname: Ducos-Galand fullname: Ducos-Galand, Magaly organization: Unité des Neisseria and Centre National de Référence des Méningocoques, Institut Pasteur, Paris, France – sequence: 3 givenname: Annie surname: Guiyoule fullname: Guiyoule, Annie organization: Unité des Neisseria and Centre National de Référence des Méningocoques, Institut Pasteur, Paris, France – sequence: 4 givenname: René surname: Pirès fullname: Pirès, René organization: Unité des Neisseria and Centre National de Référence des Méningocoques, Institut Pasteur, Paris, France – sequence: 5 givenname: Jean-Michel surname: Alonso fullname: Alonso, Jean-Michel organization: Unité des Neisseria and Centre National de Référence des Méningocoques, Institut Pasteur, Paris, France – sequence: 6 givenname: Muhamed-Kheir surname: Taha fullname: Taha, Muhamed-Kheir email: mktaha@pasteur.fr organization: Unité des Neisseria and Centre National de Référence des Méningocoques, Institut Pasteur, Paris, France |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15180205$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/13130402$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0ctu1DAUBmALFdEL8AQImQUIFgE7vsXsqkLbkQqMKEhVN5aT2OCS2MF2KmbHvsu-IU9CRhl1VoiVj3U-HV_-fbDjgzcAPMboNUYVf0OEEETeA3uYEVFwJvHOVCNWFbQi1S7YT-kKIYwrxB6AXUwwQRSVe-Dmo3Epmeg07I13_pvLrnUJnueonU9wkUKns2mhjaGHC3-tk7s2U2FNk12YhPPwOGrfGPgSSyn__L4tESpfvYXL78aHvBpMgtq38NBnV7uQXQPPx9SYYb3tXF7Bpc7ZRJ8egvtWd8k82qwH4Ovx-y9Hp8XZp5PF0eFZ0VBGcmE4Y7RpqNaUtFVtW24EpshKxJkQFbOCWDm9ELe41m1DKal1VVZE0hZZgQk5AC_muUMMP0eTsurddKGu096EMSlBOK14Kf8LscQcCYK2sIkhpWisGqLrdVwpjNQ6HzXnM8Gnm4lj3Zt2yzaBTOD5BujU6M6uf9alrWNTgiVik3s2uzAO_z7syWyuUg7xTlHKS4751C7mtkvZ_Lpr6_hDcUEEU6cXl-rzBZbvTi6X6gP5CyJqvEg |
CODEN | CIDIEL |
CitedBy_id | crossref_primary_10_1016_S0140_6736_16_30654_7 crossref_primary_10_3390_antibiotics5040035 crossref_primary_10_1016_j_clinmicnews_2005_03_002 crossref_primary_10_1016_j_tmaid_2007_10_002 crossref_primary_10_1016_S0338_9898_04_90019_4 crossref_primary_10_1016_S0755_4982_04_98708_8 crossref_primary_10_1128_JCM_43_3_1477_1479_2005 crossref_primary_10_1016_S1166_8598_04_20356_8 crossref_primary_10_1002_pro_4654 crossref_primary_10_1016_j_arcped_2004_11_018 crossref_primary_10_1111_j_1574_6976_2006_00048_x crossref_primary_10_1128_AAC_00378_16 crossref_primary_10_1128_JCM_42_9_4158_4163_2004 crossref_primary_10_1517_14728210903120887 crossref_primary_10_1016_j_jmb_2006_02_025 crossref_primary_10_1016_j_vaccine_2016_02_014 crossref_primary_10_1007_s10096_005_1283_0 crossref_primary_10_1016_j_micinf_2005_01_003 crossref_primary_10_1016_S1279_7960_05_83701_5 crossref_primary_10_1016_S1634_7358_07_70396_0 crossref_primary_10_1128_AAC_50_3_887_892_2006 crossref_primary_10_1093_jac_dkl066 crossref_primary_10_1097_INF_0b013e3181d3ce32 crossref_primary_10_1016_S0140_6736_07_61016_2 crossref_primary_10_3109_00365540903292682 crossref_primary_10_1016_j_micpath_2019_103571 crossref_primary_10_1016_j_idc_2004_04_003 crossref_primary_10_1586_14760584_5_3_319 crossref_primary_10_1007_s15010_013_0418_y crossref_primary_10_1016_S0338_9898_04_90018_2 crossref_primary_10_1016_j_arcped_2006_11_002 crossref_primary_10_1016_j_medmal_2009_02_025 crossref_primary_10_1016_j_micinf_2005_06_012 crossref_primary_10_1016_S1634_6939_05_41758_5 crossref_primary_10_1074_jbc_M313552200 crossref_primary_10_1016_S0755_4982_05_83936_3 crossref_primary_10_1128_JCM_44_5_1744_1754_2006 crossref_primary_10_1128_aac_02383_21 crossref_primary_10_1016_j_arcped_2014_04_025 crossref_primary_10_1016_S1473_3099_15_00217_0 crossref_primary_10_4161_hv_22166 crossref_primary_10_1016_S1636_5410_06_70392_0 crossref_primary_10_3390_jcm12030849 crossref_primary_10_1097_PEC_0b013e318294f709 crossref_primary_10_11604_pamj_2024_47_56_42328 crossref_primary_10_1128_AAC_00994_08 crossref_primary_10_1086_421022 crossref_primary_10_1097_QCO_0b013e3282a64700 crossref_primary_10_1099_jmm_0_000743 crossref_primary_10_1128_AAC_01812_09 crossref_primary_10_1016_j_eimc_2010_07_016 crossref_primary_10_1007_s00431_012_1924_0 crossref_primary_10_1016_j_medmal_2009_02_015 crossref_primary_10_1016_j_pratan_2009_11_002 crossref_primary_10_1086_379719 crossref_primary_10_1128_AAC_01077_09 crossref_primary_10_1016_j_medmal_2009_02_018 crossref_primary_10_1007_s11908_007_0047_7 crossref_primary_10_1128_AAC_00412_07 crossref_primary_10_1099_acmi_0_000157 crossref_primary_10_1128_JCM_00221_08 crossref_primary_10_3201_eid1207_051624 crossref_primary_10_1016_j_emcmi_2004_03_003 |
Cites_doi | 10.1111/j.1469-0691.1998.tb00675.x 10.1099/0022-1317-51-10-855 10.1016/S0140-6736(83)91846-9 10.1086/313599 10.1016/S0732-8893(01)00289-9 10.1016/S0140-6736(88)91469-9 10.1093/jac/47.3.285 10.1007/BF00182388 10.1056/NEJM199703063361007 10.1128/AAC.45.12.3625-3628.2001 10.1128/AAC.32.5.706 10.1128/AAC.44.4.1116-1116.2000 10.1128/AAC.40.3.646 10.1016/0140-6736(90)90985-E 10.1016/S0140-6736(00)03502-9 10.1017/S0950268801006549 10.1093/clinids/7.4.504 10.1128/JCM.35.3.745-750.1997 10.1016/S0140-6736(02)95343-2 10.1093/clinids/18.2.161 10.1007/BF01591498 10.1097/00006454-198705000-00003 10.1007/BF01964130 10.1128/AAC.44.6.1705-1707.2000 10.3201/eid0701.010130 10.1086/340414 10.1056/NEJM199809243391302 10.1111/j.1574-6968.1987.tb02626.x 10.1086/368170 10.1128/AAC.38.6.1256 |
ContentType | Journal Article |
Copyright | Copyright 2003 The Infectious Diseases Society of America 2003 by the Infectious Diseases Society of America 2003 2004 INIST-CNRS |
Copyright_xml | – notice: Copyright 2003 The Infectious Diseases Society of America – notice: 2003 by the Infectious Diseases Society of America 2003 – notice: 2004 INIST-CNRS |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL C1K 7X8 |
DOI | 10.1086/377739 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE Bacteriology Abstracts (Microbiology B) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1537-6591 |
EndPage | 920 |
ExternalDocumentID | 10_1086_377739 13130402 15180205 10.1086/377739 4462616 ark_67375_HXZ_RX19DGZP_M |
Genre | Journal Article |
GeographicLocations | France Europe Paris Ile-de-France |
GeographicLocations_xml | – name: France |
GroupedDBID | --- ..I .2P .GJ .I3 .ZR 08P 0R~ 1TH 29B 2AX 2WC 36B 3O- 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 AABJS AABMN AABZA AACGO AACZT AAESY AAIYJ AAJKP AAJQQ AAMVS AANCE AAOGV AAPQZ AAPXW AAQQT AARHZ AASNB AAUQX AAVAP AAYOK ABBHK ABEUO ABIXL ABJNI ABLJU ABNHQ ABOCM ABPLY ABPTD ABQLI ABSAR ABTLG ABWST ABXSQ ABXVV ACGFO ACGFS ACIMA ACPRK ACUFI ACUTO ACYHN ADACV ADBBV ADEIU ADGZP ADHKW ADHZD ADIPN ADJQC ADORX ADQLU ADRIX ADRTK ADULT ADVEK ADYVW ADZLD ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFIYH AFOFC AFRAH AFXAL AFXEN AGINJ AGQXC AGSYK AGUTN AHMBA AHXPO AI. AIAGR AIKOY AIMBJ AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN AQKUS AQVQM ASMCH ASPBG AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BCRHZ BEYMZ BGYMP BHONS BSCLL BTRTY BVRKM BYORX C1A C45 CASEJ CDBKE CS3 CZ4 DAKXR DCCCD DIK DILTD DNJUQ DOOOF DPORF DPPUQ DU5 DWIUU D~K E3Z EBS EE~ EJD EMOBN ENERS ESX F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H5~ HAR HQ3 HTVGU HVGLF HW0 HZ~ IOX J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KAQDR KBUDW KOP KSI KSN L7B M49 MHKGH MJL ML0 N4W N9A NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 VH1 W8F X7H YAYTL YKOAZ YXANX ZA5 ZGI ~91 ~S- AANRK ALXQX AAUAY ABQNK ADQBN ATGXG IPSME 08R 1KJ 6.Y 70D AAPBV AAPGJ AAPNW AAWDT ABKDP ABNKS ABPTK ABSMQ ABZBJ ACFRR ACPQN ACUTJ ADEYI ADOCK AEKPW AFYAG AGKEF AGKRT AIJHB APJGH AQDSO BZKNY EIHJH H13 IQODW MBLQV OBFPC O~Y Y6R ADQXQ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL C1K 7X8 |
ID | FETCH-LOGICAL-c453t-e6554cc4aa43d8bfd6e7140f90657785f73f91311d1badc443ba828394d0f7133 |
ISSN | 1058-4838 |
IngestDate | Fri Aug 16 00:15:59 EDT 2024 Fri Aug 16 23:00:13 EDT 2024 Thu Sep 12 16:45:14 EDT 2024 Thu May 23 23:09:17 EDT 2024 Sun Oct 22 16:04:10 EDT 2023 Wed Sep 11 04:50:39 EDT 2024 Fri Feb 02 07:04:17 EST 2024 Sun Mar 31 11:38:32 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Chemoprophylaxis Prevalence Drug susceptibility test Neisseriaceae Serogroup Neisseria meningitidis Epidemiology Infection Prevention Penicillin derivatives Heterogeneity Phenotype Treatment Surveillance Medical prescription Bacteriosis Bacteria Micrococcales Antibacterial agent Clinical isolate Meningococcal disease |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c453t-e6554cc4aa43d8bfd6e7140f90657785f73f91311d1badc443ba828394d0f7133 |
Notes | istex:ECB0E01723F8C0F2E18E981DF67EBBC1C6EF3B6F ark:/67375/HXZ-RX19DGZP-M ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/cid/article-pdf/37/7/912/1167819/37-7-912.pdf |
PMID | 13130402 |
PQID | 19160730 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_73648629 proquest_miscellaneous_19160730 crossref_primary_10_1086_377739 pubmed_primary_13130402 pascalfrancis_primary_15180205 oup_primary_10_1086_377739 jstor_primary_4462616 istex_primary_ark_67375_HXZ_RX19DGZP_M |
PublicationCentury | 2000 |
PublicationDate | 2003-10-01 |
PublicationDateYYYYMMDD | 2003-10-01 |
PublicationDate_xml | – month: 10 year: 2003 text: 2003-10-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Chicago, IL |
PublicationPlace_xml | – name: Chicago, IL – name: United States |
PublicationTitle | Clinical infectious diseases |
PublicationTitleAbbrev | Clinical Infectious Diseases |
PublicationTitleAlternate | Clinical Infectious Diseases |
PublicationYear | 2003 |
Publisher | The University of Chicago Press University of Chicago Press |
Publisher_xml | – name: The University of Chicago Press – name: University of Chicago Press |
References | Bray (5_16309243) 1995; 24 (10_28613308) 1987; 48 Mendelman (26_4964142) 1988; 32 Guibourdenche (12_16696395) 1997; 35 Van Esso (3_14188164) 1987; 6 Tondella (18_11087415) 2001; 7 V zquez (8_16268009) 1996; 15 Galimand (17_6154549) 1998; 339 Botha (4_4844067) 1988; 1 (21_38508165) 2000; 30 Quagliarello (1_16685350) 1997; 336 (30_38492989) 2003; 187 Antignac (31_11401654) 2001; 45 Abadi (16_16442955) 1996; 40 Shultz (19_6573173) 2000; 44 Spratt (25_9783206) 1992; 34 (14_38419991) 2002; 185 Antignac (11_11053969) 2001; 47 Carter (15_15612941) 1994; 38 Jones (27_5592185) 1990; 335 Dillon (6_8910115) 1983; 1 Taha (13_10613384) 2000; 356 Van Looveren (20_19187386) 1998; 4 Arreaza (23_10321317) 2000; 44 (29_38282037) 1994; 18 TROTTER (24_17332538) 2002; 51 Frasch (9_13604756) 1985; 7 Richter (22_11384370) 2001; 41 Sutcliffe (2_4867809) 1988; 1 Kyaw (28_17044791) 2002; 128 Fontanals (7_5217760) 1989; 8 |
References_xml | – volume: 4 start-page: 224 issn: 1198-743X issue: 4 year: 1998 ident: 20_19187386 publication-title: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases doi: 10.1111/j.1469-0691.1998.tb00675.x contributor: fullname: Van Looveren – volume: 51 start-page: 855 issn: 0022-2615 issue: 10 year: 2002 ident: 24_17332538 publication-title: Journal of Medical Microbiology doi: 10.1099/0022-1317-51-10-855 contributor: fullname: TROTTER – volume: 1 start-page: 779 issn: 0140-6736 issue: 8328 year: 1983 ident: 6_8910115 publication-title: Lancet doi: 10.1016/S0140-6736(83)91846-9 contributor: fullname: Dillon – volume: 30 start-page: 212 issn: 1058-4838 issue: 1 year: 2000 ident: 21_38508165 publication-title: Clinical Infectious Diseases doi: 10.1086/313599 – volume: 41 start-page: 83 issn: 0732-8893 issue: 1-2 year: 2001 ident: 22_11384370 publication-title: Diagnostic microbiology and infectious disease doi: 10.1016/S0732-8893(01)00289-9 contributor: fullname: Richter – volume: 1 start-page: 657 issn: 0140-6736 issue: 8586 year: 1988 ident: 2_4867809 publication-title: Lancet doi: 10.1016/S0140-6736(88)91469-9 contributor: fullname: Sutcliffe – volume: 47 start-page: 285 issn: 0305-7453 issue: 3 year: 2001 ident: 11_11053969 publication-title: Journal of Antimicrobial Chemotherapy doi: 10.1093/jac/47.3.285 contributor: fullname: Antignac – volume: 34 start-page: 115 issn: 1432-1432 issue: 2 year: 1992 ident: 25_9783206 publication-title: Journal of Molecular Evolution doi: 10.1007/BF00182388 contributor: fullname: Spratt – volume: 336 start-page: 708 issn: 0028-4793 issue: 10 year: 1997 ident: 1_16685350 publication-title: New England Journal of Medicine doi: 10.1056/NEJM199703063361007 contributor: fullname: Quagliarello – volume: 45 start-page: 3625 issn: 0066-4804 issue: 12 year: 2001 ident: 31_11401654 publication-title: Antimicrobial Agents and Chemotherapy doi: 10.1128/AAC.45.12.3625-3628.2001 contributor: fullname: Antignac – volume: 32 start-page: 706 issn: 0066-4804 issue: 5 year: 1988 ident: 26_4964142 publication-title: Antimicrobial Agents and Chemotherapy doi: 10.1128/AAC.32.5.706 contributor: fullname: Mendelman – volume: 44 start-page: 1116 issn: 0066-4804 issue: 4 year: 2000 ident: 19_6573173 publication-title: Antimicrobial Agents and Chemotherapy doi: 10.1128/AAC.44.4.1116-1116.2000 contributor: fullname: Shultz – volume: 40 start-page: 646 issn: 0066-4804 issue: 3 year: 1996 ident: 16_16442955 publication-title: Antimicrobial Agents and Chemotherapy doi: 10.1128/AAC.40.3.646 contributor: fullname: Abadi – volume: 335 start-page: 863 issn: 0140-6736 issue: 8693 year: 1990 ident: 27_5592185 publication-title: Lancet doi: 10.1016/0140-6736(90)90985-E contributor: fullname: Jones – volume: 356 start-page: 2159 issn: 0140-6736 issue: 9248 year: 2000 ident: 13_10613384 publication-title: Lancet doi: 10.1016/S0140-6736(00)03502-9 contributor: fullname: Taha – volume: 128 start-page: 149 issn: 1469-4409 issue: 2 year: 2002 ident: 28_17044791 publication-title: Epidemiology and Infection (Print) doi: 10.1017/S0950268801006549 contributor: fullname: Kyaw – volume: 24 start-page: 1910 issn: 0032-7867 issue: 39 year: 1995 ident: 5_16309243 publication-title: La Presse m dicale contributor: fullname: Bray – volume: 7 start-page: 504 issn: 0162-0886 issue: 4 year: 1985 ident: 9_13604756 publication-title: Reviews of infectious diseases doi: 10.1093/clinids/7.4.504 contributor: fullname: Frasch – volume: 35 start-page: 745 issn: 0095-1137 issue: 3 year: 1997 ident: 12_16696395 publication-title: Journal of Clinical Microbiology doi: 10.1128/JCM.35.3.745-750.1997 contributor: fullname: Guibourdenche – volume: 1 start-page: 54 issn: 0140-6736 issue: 8575-6 year: 1988 ident: 4_4844067 publication-title: Lancet doi: 10.1016/S0140-6736(02)95343-2 contributor: fullname: Botha – volume: 18 start-page: 161 issn: 1058-4838 issue: 2 year: 1994 ident: 29_38282037 publication-title: Clinical Infectious Diseases doi: 10.1093/clinids/18.2.161 – volume: 15 start-page: 181 issn: 0934-9723 issue: 2 year: 1996 ident: 8_16268009 publication-title: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology doi: 10.1007/BF01591498 contributor: fullname: V zquez – volume: 6 start-page: 438 issn: 0891-3668 issue: 5 year: 1987 ident: 3_14188164 publication-title: The Pediatric infectious disease journal doi: 10.1097/00006454-198705000-00003 contributor: fullname: Van Esso – volume: 8 start-page: 90 issn: 0934-9723 issue: 1 year: 1989 ident: 7_5217760 publication-title: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology doi: 10.1007/BF01964130 contributor: fullname: Fontanals – volume: 44 start-page: 1705 issn: 0066-4804 issue: 6 year: 2000 ident: 23_10321317 publication-title: Antimicrobial Agents and Chemotherapy doi: 10.1128/AAC.44.6.1705-1707.2000 contributor: fullname: Arreaza – volume: 7 start-page: 163 issn: 1080-6040 issue: 1 year: 2001 ident: 18_11087415 publication-title: Emerging infectious diseases doi: 10.3201/eid0701.010130 contributor: fullname: Tondella – volume: 185 start-page: 1596 issn: 0022-1899 issue: 11 year: 2002 ident: 14_38419991 publication-title: Journal of Infectious Diseases doi: 10.1086/340414 – volume: 339 start-page: 868 issn: 0028-4793 issue: 13 year: 1998 ident: 17_6154549 publication-title: New England Journal of Medicine doi: 10.1056/NEJM199809243391302 contributor: fullname: Galimand – volume: 48 start-page: 367 issn: 1574-6968 year: 1987 ident: 10_28613308 publication-title: FEMS Microbiology Letters doi: 10.1111/j.1574-6968.1987.tb02626.x – volume: 187 start-page: 1010 issn: 0022-1899 issue: 6 year: 2003 ident: 30_38492989 publication-title: Journal of Infectious Diseases doi: 10.1086/368170 – volume: 38 start-page: 1256 issn: 0066-4804 issue: 6 year: 1994 ident: 15_15612941 publication-title: Antimicrobial Agents and Chemotherapy doi: 10.1128/AAC.38.6.1256 contributor: fullname: Carter |
SSID | ssj0011805 |
Score | 2.0535219 |
Snippet | Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999–2002, a total of 2167 clinical isolates of N. meningitidis... Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis... |
SourceID | proquest crossref pubmed pascalfrancis oup jstor istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 912 |
SubjectTerms | Alleles Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial diseases Bacterial diseases of the nervous system. Bacterial myositis Biological and medical sciences Chemoprevention Drug Resistance, Bacterial France Human bacterial diseases Humans Infections Infectious diseases Major Articles Medical sciences Meningitis, Meningococcal Meningococcal infections Microbial Sensitivity Tests Neisseria meningitidis Neisseria meningitidis - drug effects Neisseria meningitidis - genetics Penicillin Penicillin G - pharmacology Penicillin Resistance - genetics Pharmacology. Drug treatments Phenotype Phenotypes Serotyping Sulfonamides Surveillance |
Title | Neisseria meningitidis Strains Isolated from Invasive Infections in France (1999–2002): Phenotypes and Antibiotic Susceptibility Patterns |
URI | https://api.istex.fr/ark:/67375/HXZ-RX19DGZP-M/fulltext.pdf https://www.jstor.org/stable/4462616 https://www.ncbi.nlm.nih.gov/pubmed/13130402 https://search.proquest.com/docview/19160730 https://search.proquest.com/docview/73648629 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKJiEkhPgYowOGHxCCh6CkTuKYt2nd1sJaKmilai-R4yRQgdJpbYHxD_jX3GvH-RBMfLxEURo5Sc-Jc3197jEhT1P8aqvEcyKWwgBFidQBmJkjXS9KApYGTFe5jsbhYOa_ngfzTudrs7pknbxU339bV_I_qMIxwBWrZP8B2apROAD7gC9sAWHY_hXG40zPpi9wIWiz8tAiXaxwplmi8mUIV5cYUeoakmHxRWqt-rDUXxkJuV5ZQwea2iqgp71SBSYKJh-zYokpWmPjfFBgeckSDV7fb1ZaDaOFtZdo849pxVUz0D20FZdW7bVZ2cmgKorHFj8UUrVSqn2U0DsnleKydvDfLC6Xm8_tBOwEeuyG7tGmL2ohnO1x3UBnNKNml2x8YErq8Ub_KkrNtflUC11H9-tXwNWTUoxzboyS2jbb47fx8ez0NJ4ezafXyHaPiwBH7f3hm2r6yYu09rW6t8aiVKbVVhSzjS_kNytotZWSN8_lCv7m3KyPcvUARgcy09vkVjkCoQeGTndIJyvukuujUmNxj_yoWEWbrKIlq6hlFUVWUcsqWrOKLgpqWEWfV5x68YrWfKKALa35RNt8opZPO2R2fDQ9HDjlgh2O8gO2drIQglOlfCl9lkZJnoYZ-kHmAuJczqMg5ywX6O-UeolMle-zRMKInwk_dXPMltwnW8WyyB4Q6qrUS7NA6AImqfIohx2ZcBWqzE0E75InFoD43PiyxFpPEYWxgahLnmlcqp_lxSdUMfIgHszP4ndzT_RPzibxqEt2NHDVib4Po3wv7JI9APLK1vdb-NanBeip6AZwgxbwGHpsnIaTRQYvW-wJNHVk7tVncBb68LhwkV3DlLp1BjGn7_b2_tj6Q3Kjft0eka31xSZ7DPHzOtnXXP8JvZPF9w |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neisseria+meningitidis+Strains+Isolated+from+Invasive+Infections+in+France+%281999-2002%29%3A+Phenotypes+and+Antibiotic+Susceptibility+Patterns&rft.jtitle=Clinical+infectious+diseases&rft.au=Antignac%2C+A&rft.au=Ducos-Galand%2C+M&rft.au=Guiyoule%2C+A&rft.au=Pires%2C+R&rft.date=2003-10-01&rft.issn=1058-4838&rft.volume=37&rft.issue=7&rft.spage=912&rft.epage=920&rft_id=info:doi/10.1086%2F377739&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon |